The event is the culmination of a vision to revolutionize search and rescue using #robots in #underground domains. Tune in Sept 21–24 on SubTV:
Dr. The book launch will happen on September 4th, at 3 p.m. (Pacific Time) in Book Passage Ferry Building Store in San Francisco, California!
Please come to have an in-person chat with Dr. Katcher.
Dr. Harold Katcher is one of the discoverers of the human breast cancer gene (BRCA1), and has thousands of citations in the scientific literature, with publications ranging from protein structure to bacteriology, biotechnology, bioinformatics and biochemistry. He was the Academic Director for Natural Sciences for the Asian Division of the University of Maryland Global Campus, and nowadays is Chief Scientific Officer at Yuvan Research Inc., which is working on the development of rejuvenation treatments.
https://www.bookpassage.com/event/harold-katcher-illusion-kn…ding-store.
https://www.ntzplural.com/harold-katcher-launches-book.
https://www.facebook.com/events/553354852782737?ref=newsfeed.
#haroldkatcher #sanfrancisco #california #booklaunch #biotechnology #rejuvenation #aging.
Created with the voices from LOVO @ www.lovo.ai.
You can also just see the first stage flip round on its way to A Shortfall of Gravitas. Credit: NASA.
Sorry if I look a bit horrible, I’ve been a bit ill the past few days. But the V2 sure doesn’t look half bad. She does indeed fly as good as she looks.
As mentioned before the feeling of the tail is a big improvement, the head itself feels much tighter and more locked in, in part thanks to the more rigid frame. It also flips on a dime too, thanks to the lowered head and more central centre of gravity.
All in all I’m loving this model. It’s getting dark now, I should probably go home… one more flight maybe 😂
ALIGN TREX Models.
XLPower.
#TeamAT #Specter700V2 #XLpower #ATModels
A cancer vaccine could be an effective way to prevent cancer from evolving and becoming resistant to treatment, new research suggests.
Scientists were investigating the use of a cancer-killing virus in clinical trials, and observed, as they had also seen in mice, that although some patients initially responded to the treatment, their tumours soon became resistant.
The researchers showed that the specific mutations causing tumour cells to become resistant to the viral treatment, could be anticipated and exploited using a vaccine which, when tested in mice, was shown to trigger the immune system to destroy treatment resistant tumour cells.
Scientists have developed a cancer vaccine that in mice was shown to trigger the immune system to destroy treatment-resistant tumor cells.